SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Claus Zehetner, Rudolf Kirchmair, Martina Kralinger, Gerhard Kieselbach, Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy, Acta Ophthalmologica, 2013, 91, 6
  2. 2
    Ina M. Kacso, Gabriel Kacso, Endothelial cell–selective adhesion molecule in diabetic nephropathy, European Journal of Clinical Investigation, 2012, 42, 11
  3. 3
    Ina Maria Kacso, Cosmina Ioana Bondor, Gabriel Kacso, Soluble serum Klotho in diabetic nephropathy: Relationship to VEGF-A, Clinical Biochemistry, 2012, 45, 16-17, 1415

    CrossRef

  4. 4
    S.M. Titan, J.M. Vieira, W.V. Dominguez, S.R.S. Moreira, A.B. Pereira, R.T. Barros, R. Zatz, Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy, Journal of Diabetes and its Complications, 2012, 26, 6, 546

    CrossRef

  5. 5
    Peter Kubisz, Peter Chudý, Ján Staško, Peter Galajda, Pavol Hollý, Robert Vyšehradský, Marián Mokáň, Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus, Acta Diabetologica, 2010, 47, 2, 119

    CrossRef

  6. 6
    P. L. Kristensen, U. Pedersen-Bjergaard, C. Schalkwijk, N. V. Olsen, B. Thorsteinsson, Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes, European Journal of Endocrinology, 2010, 163, 3, 391

    CrossRef

  7. 7
    Erdinc Aydin, Helin Deniz Demir, Semsettin Sahin, Plasma and Aqueous Humor Angiotensin-Converting Enzyme Levels in Patients with Diabetic Retinopathy, Current Eye Research, 2010, 35, 3, 230

    CrossRef

  8. 8
    Javad Tavakkoly-Bazzaz, Mahsa M. Amoli, Vera Pravica, Ramesh Chandrasecaran, Andrew J. M. Boulton, Bagher Larijani, Ian V. Hutchinson, VEGF gene polymorphism association with diabetic neuropathy, Molecular Biology Reports, 2010, 37, 7, 3625

    CrossRef

  9. 9
    Mark B. Zimering, Robert J. Anderson, Thomas E. Moritz, Ling Ge, Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial, Metabolism, 2009, 58, 3, 393

    CrossRef

  10. 10
    HYE WON KIM, GANG JEE KO, YOUNG SUN KANG, MI HWA LEE, HYE KYOUNG SONG, HYOUNG KYU KIM, DAE RYONG CHA, Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients, Nephrology, 2009, 14, 7
  11. 11
    Lopa Leach, Alice Taylor, Flavia Sciota, Vascular dysfunction in the diabetic placenta: causes and consequences, Journal of Anatomy, 2009, 215, 1
  12. 12
    Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip, Vascular endothelial growth factor in the management of hepatocellular carcinoma, Cancer, 2009, 115, 21
  13. 13
    Sayeeda Rahman, Tahminur Rahman, Aziz Al-Shafi Ismail, Abdul Rahman A Rashid, Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis, Diabetes, Obesity and Metabolism, 2007, 9, 6
  14. 14
    P K Y Goon, G Y H Lip, Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy, Eye, 2007, 21, 6, 838

    CrossRef

  15. 15
    Aydan Celebiler Cavusoglu, Bilgili Sibel, Dogan Aylin, Aslanca Dilek, Yılmaz Feray, Karaca Baysal, Serum vascular endothelial growth factor and diabetic nephropathy progression, Medicinal Chemistry Research, 2007, 16, 4, 162

    CrossRef

  16. 16
    Dilara Seckin, Necip Ilhan, Nevin Ilhan, Sabahattin Ertugrul, Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus, Diabetes Research and Clinical Practice, 2006, 73, 2, 191

    CrossRef

  17. 17
    Allan Flyvbjerg, Inhibition and reversibility of renal changes: lessons from diabetic kidney disease, Acta Paediatrica, 2006, 95,
  18. 18
    I G Lee, S L Chae, J C Kim, Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy, Eye, 2006, 20, 5, 546

    CrossRef

  19. 19
    Ping Chen, Gloria M. Scicli, Meng Guo, Joseph D. Fenstermacher, David Dahl, Paul A. Edwards, A. Guillermo Scicli, Role of angiotensin II in retinal leukostasis in the diabetic rat, Experimental Eye Research, 2006, 83, 5, 1041

    CrossRef

  20. 20
    Gemma Francisco, Cristina Hernández, Rafael Simó, Serum markers of vascular inflammation in dyslipemia, Clinica Chimica Acta, 2006, 369, 1, 1

    CrossRef

  21. 21
    Caroline Schmidt-Lucke, Funmi Belgore, Dirk Reinhold, Siegfried Ansorge, Helmut U. Klein, J. André Schmidt-Lucke, Gregory Y.H. Lip, Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers, International Journal of Cardiology, 2005, 100, 2, 207

    CrossRef

  22. 22
    Nan Hee Kim, Jeong Heon Oh, Ji A. Seo, Kye Won Lee, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Young Sun Kang, Sang Youb Han, Kum Hyun Han, Yi Hwa Ji, Dae Ryong Cha, Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy, Kidney International, 2005, 67, 1, 167

    CrossRef

  23. 23
    N. H. Kim, K. B. Kim, D. L. Kim, S. G. Kim, K. M. Choi, S. H. Baik, D. S. Choi, Y. S. Kang, S. Y. Han, K. H. Han, Y. H. Ji, D. R. Cha, Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus, Diabetic Medicine, 2004, 21, 6
  24. 24
    Bieke F. Schrijvers, Allan Flyvbjerg, An S. De Vriese, The role of vascular endothelial growth factor (VEGF) in renal pathophysiology, Kidney International, 2004, 65, 6, 2003

    CrossRef

  25. 25
    Rayaz A Malik, Current and Future Strategies for the Management of Diabetic Neuropathy, Treatments in Endocrinology, 2003, 2, 6, 389

    CrossRef

  26. 26
    Matthew A Speicher, Ronald P Danis, Mark Criswell, Linda Pratt, Pharmacologic therapy for diabetic retinopathy, Expert Opinion on Emerging Drugs, 2003, 8, 1, 239

    CrossRef

  27. 27
    Atul Jain, David Sarraf, Donald Fong, Preventing diabetic retinopathy through control of systemic factors, Current Opinion in Ophthalmology, 2003, 14, 6, 389

    CrossRef

  28. 28
    K Shimada, T Baba, S Neugebauer, A Onozaki, D Yamada, S Midorikawa, W Sato, T Watanabe, Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy, Journal of Diabetes and its Complications, 2002, 16, 6, 386

    CrossRef

  29. You have free access to this content29
    Current Awareness, Diabetes/Metabolism Research and Reviews, 2001, 17, 6